A phase III, randomized, double-blind, multicenter study to compare the efficacy, safety, pharmacokinetics, and immunogenicity between SB8 (proposed bevacizumab biosimilar) and reference bevacizumab in patients with metastatic or recurrent nonsquamous non-small cell lung cancer
Reck, Martin, Luft, Alexander, Bondarenko, Igor, Shevnia, Serhii, Trukhin, Dmytro, Kovalenko, Nadezhda V., Vacharadze, Kakha, Andrea, Fülöp, Hontsa, Anatoliy, Choi, Jihye, Shin, Donghoon
Published in Lung cancer (Amsterdam, Netherlands) (01.08.2020)
Published in Lung cancer (Amsterdam, Netherlands) (01.08.2020)
Get full text
Journal Article
Untreated metastatic diffuse gastric adenocarcinoma (DGAC): Randomized phase III study of S-1 and cisplatin vs. 5-FU and cisplatin (the DIGEST trial)
Ajani, Jaffer A., Abramov, Mikhail, Bondar, Volodymyr, Bondarenko, Igor, Shparyk, Yaroslav V., Gorbunova, Vera, Anatoliy, Hontsa, Vinnyk, Yuriy, Alsina, Maria, Lazarev, Sergey, Feliu, Jaime, Elme, Anneli, Esko, Vivian, Rosati, Gerardo, Abdalla, Kathia Cristina, Verma, Udit N., Benedetti, Fabio M., Aoyama, Takekazu, Mizuguchi, Hirokazu, Makris, Lukas
Published in Journal of clinical oncology (20.05.2015)
Published in Journal of clinical oncology (20.05.2015)
Get full text
Journal Article